Hepatitis C-pipeline update

Nature Reviews Drug Discovery

Volumn 10, Issue 2, 2011, Pages 93-94

  Melnikova, Irena ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABT 450; ACH 1625; ANTIANEMIC AGENT; BI 207127; BOCEPREVIR; DANOPREVIR; GS 9190; IDX 184; IDX 320; INX 189; MK 3281; NARLAPREVIR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PROTEINASE INHIBITOR; PSI 7977; PSI 938; RECOMBINANT ALPHA2B INTERFERON; RG 7128; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STEROID; TELAPREVIR; TMC 435350; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANIPREVIR; VX 222; VX 813;

ANEMIA; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; DRUG APPROVAL; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HEPATITIS C; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; CONGRESSES AS TOPIC; DRUG DISCOVERY; HEPATITIS C, CHRONIC; HUMANS; OLIGOPEPTIDES;

EID: 79551596261     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd3361     Document Type: Short Survey

References (3)

1. Ghany, M. G., Strader, D. B., Thomas, D. L. & Seeff, L. B. Diagnosis, Management, And treatment of hepatitis C: an update. Hepatology 49, 1335-1374 (2009).
2. The 61st Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2010. Hepatology 52 (Suppl. S1), IiA-ivA, 1A-1352A (2010).
3. Sarrazin, C. & Zeuzem, S. Resistance to direct antiviral agents in patients with hepatitis C virus infection. Gastroenterology 138, 447-462 (2010).